Krognes Steve E.

EDGAR CIK 0001666236

Denali Therapeutics Inc. - DNLI

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director
Direct Buys
0
$0
0 Shares
Direct Sells
7
($3.60) M
-160,873 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
09/30/2024
10b5-1
10/02/2024
Sell
-30,000 @ $29.03
 ($870,900) 29,096 (-50.76%) Direct
08/20/2024
08/22/2024
Sell
-1,727 @ $23.79
 ($41,085) 32,677 (-5.02%) Direct
07/01/2024
10b5-1
07/03/2024
Sell
-30,000 @ $22.12
 ($663,668) 34,404 (-46.58%) Direct
06/13/2024
07/03/2024
Sell
-688 @ $21.79
 ($14,992) 52,620 (-1.29%) Direct
04/01/2024
10b5-1
04/02/2024
Sell
-92,500 @ $20.50
 ($1,896,250) 47,341 (-66.15%) Direct
02/13/2024
02/15/2024
Sell
-2,750 @ $17.29
 ($47,548) 139,841 (-1.93%) Direct
01/05/2024
01/09/2024
Sell
-3,208 @ $19.43
 ($62,331) 142,591 (-2.20%) Direct